Comparison of the Diagnostic Performance of Antigen B Purified from Sheep Hydatid Cyst Fluid (HCF) with Commercial ELISA Kit
CONCLUSION: Antigen B produced from hydatid cyst fluid is a promising option for serological identification of hydatid cysts in both infected and healthy individuals. In an indirect ELISA test, hydatid fluid antigen could be used as a precise source of detection.PMID:38415436 | DOI:10.2174/0118715265281114240131045945 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 28, 2024 Category: Infectious Diseases Authors: Fatemeh Abdollahpour Darzi Hossein Asgarian-Omran Shahabeddin Sarvi Reza Valadan Maryam Hataminejad Sabah Mayahi Seyyed Ali Shariatzadeh Takatom Abbasi Tahereh Mikaeili Galeh Mahdi Fakhar Majid Fassihi Harandi Shirzad Gholami Source Type: research
Comparison of the Diagnostic Performance of Antigen B Purified from Sheep Hydatid Cyst Fluid (HCF) with Commercial ELISA Kit
CONCLUSION: Antigen B produced from hydatid cyst fluid is a promising option for serological identification of hydatid cysts in both infected and healthy individuals. In an indirect ELISA test, hydatid fluid antigen could be used as a precise source of detection.PMID:38415436 | DOI:10.2174/0118715265281114240131045945 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 28, 2024 Category: Infectious Diseases Authors: Fatemeh Abdollahpour Darzi Hossein Asgarian-Omran Shahabeddin Sarvi Reza Valadan Maryam Hataminejad Sabah Mayahi Seyyed Ali Shariatzadeh Takatom Abbasi Tahereh Mikaeili Galeh Mahdi Fakhar Majid Fassihi Harandi Shirzad Gholami Source Type: research
Comparison of the Diagnostic Performance of Antigen B Purified from Sheep Hydatid Cyst Fluid (HCF) with Commercial ELISA Kit
CONCLUSION: Antigen B produced from hydatid cyst fluid is a promising option for serological identification of hydatid cysts in both infected and healthy individuals. In an indirect ELISA test, hydatid fluid antigen could be used as a precise source of detection.PMID:38415436 | DOI:10.2174/0118715265281114240131045945 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 28, 2024 Category: Infectious Diseases Authors: Fatemeh Abdollahpour Darzi Hossein Asgarian-Omran Shahabeddin Sarvi Reza Valadan Maryam Hataminejad Sabah Mayahi Seyyed Ali Shariatzadeh Takatom Abbasi Tahereh Mikaeili Galeh Mahdi Fakhar Majid Fassihi Harandi Shirzad Gholami Source Type: research
Comparison of the Diagnostic Performance of Antigen B Purified from Sheep Hydatid Cyst Fluid (HCF) with Commercial ELISA Kit
CONCLUSION: Antigen B produced from hydatid cyst fluid is a promising option for serological identification of hydatid cysts in both infected and healthy individuals. In an indirect ELISA test, hydatid fluid antigen could be used as a precise source of detection.PMID:38415436 | DOI:10.2174/0118715265281114240131045945 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 28, 2024 Category: Infectious Diseases Authors: Fatemeh Abdollahpour Darzi Hossein Asgarian-Omran Shahabeddin Sarvi Reza Valadan Maryam Hataminejad Sabah Mayahi Seyyed Ali Shariatzadeh Takatom Abbasi Tahereh Mikaeili Galeh Mahdi Fakhar Majid Fassihi Harandi Shirzad Gholami Source Type: research
Comparison of the Diagnostic Performance of Antigen B Purified from Sheep Hydatid Cyst Fluid (HCF) with Commercial ELISA Kit
CONCLUSION: Antigen B produced from hydatid cyst fluid is a promising option for serological identification of hydatid cysts in both infected and healthy individuals. In an indirect ELISA test, hydatid fluid antigen could be used as a precise source of detection.PMID:38415436 | DOI:10.2174/0118715265281114240131045945 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 28, 2024 Category: Infectious Diseases Authors: Fatemeh Abdollahpour Darzi Hossein Asgarian-Omran Shahabeddin Sarvi Reza Valadan Maryam Hataminejad Sabah Mayahi Seyyed Ali Shariatzadeh Takatom Abbasi Tahereh Mikaeili Galeh Mahdi Fakhar Majid Fassihi Harandi Shirzad Gholami Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
CONCLUSION: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.PMID:38343046 | DOI:10.2174/0118715265209731240129042916 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - February 12, 2024 Category: Infectious Diseases Authors: Mansour Babaei Behzad Heidari Hossein Ghorbani Zahra Ahmadnia Samaneh Rouhi Mahmoud Sadeghi Haddad Zavareh Source Type: research
